Supported by: Federal Ministry of Education and Research

Company visit at Boehringer Ingelheim

Company visit at Boehringer Ingelheim

Boehringer Ingelheim is working on ground-breaking therapies that improve the lives of people and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Since its foundation in 1885, Boehringer Ingelheim has been family-owned with a long-term perspective. Around 52,000 employees serve more than 130 markets in three business areas: Human Pharmaceuticals, Animal Health and Biopharmaceutical Contract Manufacturing.

Event Information

Event Date 13.10.2022
Event End Date 13.10.2022
Individual Price Free

We are no longer accepting registration for this event